Skip to content
MedsAcross

Brand family

Opdivo

Nivolumab · ER Squibb & Sons
United States
Presentations
4
Markets
1

Opdivo is a brand of Nivolumab marketed by ER Squibb & Sons, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Nivolumab
Brand owner
ER Squibb & Sons
Registered in
United States
Strengths and forms
100 mg/10 mL injection, 120 mg/12 mL injection, 240 mg/24 mL injection, 40 mg/4 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Opdivo 100 mg/10 mL injectionIntravenous Cold chainER Squibb & SonsUS FDAAvailable on request
Opdivo 120 mg/12 mL injectionIntravenous Cold chainER Squibb & SonsUS FDAAvailable on request
Opdivo 240 mg/24 mL injectionIntravenous Cold chainER Squibb & SonsUS FDAAvailable on request
Opdivo 40 mg/4 mL injectionIntravenous Cold chainER Squibb & SonsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Opdivo

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.